F.D.A. Acknowledges “CBD Data Limited” Today – Although Pharmaceutical Approved Over One Year Ago

In a startling announcement in their ongoing attempt to regulate the CBD Industry, the Federal entity charged with the task continues to show a lack of knowledge regarding the cannabinoid extract that most believed they had firm knowledge on after hearings and decades of research. “Thus, limited systematic data exist to inform our approach,” The […]

Drug Interactions: Doctors Are Unaware And CBD Companies Can’t Give Advice

Dear Mike: My son uses CBD, he has been prescribed Omeprazole and he’s been dizzy, tired, sick, pale, and yellow. Nobody can tell us what the problem is. The CBD company said they can’t answer and the doctor told us there are no interactions. Can you help? Unfortunately, federal law prohibits CBD companies from giving […]

Breaking News: Research Proves Major Flaws In Rx CBD

Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts: By:   Mike Robinson (The former authors have vacated their positions due to ‘controversy’ over the subject matter / Edited 10/24/2018) DRAFT Abstract:    (This is not the final draft, the final will be transformed into a more scientific document by […]

Translate »